Unlocking Potential and Limits of Kinase Inhibitors: The Highway to Enhanced Cancer Targeted Therapy

Pharmaceutics. 2024 May 7;16(5):625. doi: 10.3390/pharmaceutics16050625.

Abstract

Kinases are a family of enzymes comprising over five hundred members, which, when overexpressed or hyperactivated, are implicated in the pathogenesis of numerous hematological and solid cancers [...].

Publication types

  • Editorial